Literature DB >> 7617162

Transglutaminase C in cerebellar granule neurons: regulation and localization of substrate cross-linking.

M J Perry1, S A Mahoney, L W Haynes.   

Abstract

Covalent cross-linking of cell surface proteins by the calcium-dependent enzyme transglutaminase C may be implicated in cell-cell interactions and growth regulation. We demonstrate the presence of the enzyme in rat cerebellar cortex during postnatal development. Transglutaminase C was induced in cerebellar granule neurons in culture by retinoic acid, dibutyryl- and 8-bromo-cyclic AMP analogues and by cultivation on a biomatrix substratum. Cyclic AMP analogues stimulated transglutaminase activity in protein synthesis-dependent and -independent phases. The enzyme was distributed at focal adhesion sites on the axon. By calcium-dependent covalent incorporation of the primary amine acceptor substrate, 5-(biotinamido)pentylamine, an increase in the Ca(2+)-dependent cross-linking of at least 11 substrate proteins in the presence of retinoic acid and dibutyryl-cyclic AMP was detected. Of these substrates, a subset was labelled on the surface of living granule neurons. A low-molecular-weight substrate, p18, was tentatively identified as the retinoic acid-inducible neurite-promoting factor, midkine. Transglutaminase-mediated amine incorporation, midkine and isopeptide cross-links were co-localized to axonal adhesion sites. The results provide evidence of transglutaminase C-catalysed protein cross-linking activity in cerebellar granule neurons and its possible implication in cell-substratum interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617162     DOI: 10.1016/0306-4522(94)00556-k

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

2.  Neurodegenerative diseases and transglutaminase.

Authors:  L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Hydroxamate-based colorimetric method for direct screening of transglutaminase-producing bacteria.

Authors:  Chaiwut Bourneow; Soottawat Benjakul; Aran H-Kittikun
Journal:  World J Microbiol Biotechnol       Date:  2012-02-10       Impact factor: 3.312

4.  Stabilization of collagen-tailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking.

Authors:  D Hand; D Dias; L W Haynes
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

5.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

6.  Transglutaminase-1 regulates renal epithelial cell proliferation through activation of Stat-3.

Authors:  Zhu Zhang; Jingping Xing; Li Ma; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

7.  Transglutaminase-1 protects renal epithelial cells from hydrogen peroxide-induced apoptosis through activation of STAT3 and AKT signaling pathways.

Authors:  Murugavel Ponnusamy; Maoyin Pang; Pavan Kumar Annamaraju; Zhu Zhang; Rujun Gong; Y Eugene Chin; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-26

Review 8.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

9.  Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling.

Authors:  Anthony J Filiano; Craig D C Bailey; Janusz Tucholski; Soner Gundemir; Gail V W Johnson
Journal:  FASEB J       Date:  2008-03-28       Impact factor: 5.191

10.  Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection.

Authors:  Ibtesam Almami; John M Dickenson; Alan J Hargreaves; Philip L R Bonner
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.